All In Biotech

Drug Trial Radar · NCT02958215

Phenylephrine and Hypotension During Spinal Anesthesia for Cesarean Section

A Study Evaluating Hypotension and Autonomic Nervous System Dysfunction During Spinal Anesthesia for Cesarean Section and Its Relation to the Effect of Prophylaxis Phenylephrine

Last checked: Nov 20, 2026Latest source record: May 18, 2017 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 980 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

980

Actual

Start

Jun 2016

Primary completion

May 2017

Study completion May 2017

Sponsor

Lead sponsor
Assiut UniversityAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Nov 8, 2016

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, care provider, outcomes assessor)
Primary purpose
Prevention
Who can join
Female only, from 18 years, up to 50 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Pregnant women with a positive preoperative Supine stress test were found to be a subgroup at increased risk of symptomatic hypotension after spinal anesthesia

Conditions

  • Anesthesia, Obstetrical
  • Anesthesia, Spinal

Interventions

  • PhenylephrineDrug

    it will be given as a prophylaxis for prevention of hypotension after spinal anesthesia in pregnant patients undergoing cesarean section

  • PlaceboOther

    5 ml normal saline will be given before spinal anesthesia

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Incidence of hypotensionTime frame: within first 24 hours after spinal anesthesia

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Faculty of Medicine

    Asyut, Egypt

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.